Dishman Pharmaceuticals and Chemicals has informed that the Management Committee of Board of Directors of the Company vide resolution passed in their meeting held on May 05, 2016 (which was commenced at 11.00 AM and concluded at 11.45 AM at the Registered Office of the Company), have approved the issue and allotment of 80,697,136 equity shares of Rs 2 each, as fully paid-up bonus shares in the ratio of 1 equity share for every 1 equity share held to those shareholders whose names appear in the Register of Members / List of Beneficial owners as on the Record Date i.e. on May 03, 2016. The Company is in process of execution of Corporate Action with NSDL & CDSL for credit of Bonus Equity Shares in the account of respective eligible shareholders.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: